Cohance Lifesciences, Suven Pharmaceuticals merger sanctioned by the NCLT
The Company expects to complete the amalgamation process by Q1FY26
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Suven Pharmaceuticals
Indian pharma companies focus on innovative research in foreign countries through dedicated entities
According to GlobalData’s Pharmaceutical Intelligence Center, as of 20 December 2024, there are a total of 16 drugs in the…
Cohance, Suven merger get approval from NSE and BSE
The newly formed company will operate three main verticals: Pharma CDMO, Agrochemicals CDMO, and API manufacturing
Suven to acquire controlling stake in Sapala Organics, a CDMO player
Suven has agreed to acquire an initial controlling stake, operate the business together with the selling shareholders for the next…
Suven, Cohance announce merger
The merged platform to comprise three distinct business units – Pharma CDMO, Spec Chem CDMO, and API+ (inclusive of formulations)
CSIR-IICT, NIIST, Suven Pharma sign MoU for Molnupiravir
The anti-viral drug was initially developed for the treatment of influenza and has been repurposed to treat COVID-19